Supplemental Table 4 from Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Overrepresentation analysis enrichment of MSigDB KEGG and HALLMARK pathways in the ESR1m defective RSR signature
Fields of Study & Subjects
Estrogen and related hormone effects
Breast Cancer Treatment Studies
Advanced Breast Cancer Therapies
Publication details
- Publication date
- 2 April 2026
- Language
- EN